SOL-686

N/A

Report date: 2024/01/02 14:18:55
NME

Base Information

Drug NameSOL-686
Drug Alias NameSOL-686SOL686PM-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 inhibitors
TargetsPolo like kinase 1
Therapy Area/IndicationsGanglioglioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CambridgePhoremost LtdSentinel Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSentinel Oncology Ltd
Inactive CompaniesN/A
Active IndicationsGanglioglioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A